We report the case of a pregnancy in a 25-year-old woman who was born with ectopia vesicae and split pelvis, but had not undergone any reconstructive or diversion surgery in childhood. Her antenatal period was uneventful and the infant was delivered by cesarean section at term due to breech presentation. The baby had no congenital anomalies. The postoperative period was uneventful and they were discharged from the hospital in a good general condition.
Background: Objective of current study was to compare the efficacy, safety and tolerance of misoprostol versus dinoprostone gel in induction of labour in the case of late Intra Uterine Fetal Death (IUFD) with unfavourable cervix. Methods: This prospective study included a consecutive series of 40 women gravid up to fourth with IUFD after 28 weeks of gestation between March 2013 to Feb 2014. Women were divided into two groups. Each group consisted of 20 women. First group of women received 100 μg of misoprostol per vaginally at four hourly intervals (maximum 600 μg in 24 hours). Second group of women received dinoprostone gel 0.5 mg intracervically at every 6 hours, maximum 2 doses in 24 hours. Oxytocin was given for augmentation if needed. Results: The induction-to-delivery interval was significantly shorter with the misoprostol (8.13 ± 1.62 hours vs. 14.32 ± 2.46 hours; P <0.001) group. The total dose of misoprostol needed was significantly lower than the group pretreated with dinoprostone gel (1.78 ± 0.80 vs. 3.50 ± 1.12; P <0.001). The two groups did not differ as regards complications experienced during labour and delivery significantly. Conclusions: Both regimens, misoprostol and dinoprostone are safe in induction of labour after intrauterine fetal death (IUFD). Misoprostol is more effective in terms of reducing of induction delivery interval, requirement of lesser dose.
INTRODUCTION: Chronic Kidney Disease (CKD) is dened as a disease characterized by alterations in either kidney
structure or function or both for a minimum of 3 months duration. According to the National Kidney Foundation criteria,
1 CKD has been classied into ve stages with stage 1 being the earliest or mildest CKD state and stage 5 being the most severe CKD stage. To
stage CKD, it is necessary to estimate the GFR rather than relying on serum creatinine concentration. Glomerular ltration rate (GFR), either
directly measured by computing urinary clearance of ltration marker such as inulin or estimated by calculating from different equations using
serum creatinine. is the most commonly used parameter to assess kidney function.
AIM AND OBJECTIVES: a) Establish relationship between serum CKD and eGFR
MATERIAL AND METHOD: A Cross-sectional study on 100 cases of newly diagnosed Chronic Kidney Disease patients and matched control
subjects is undertaken to study.100 Patients who are newly diagnosed as CKD are selected after proper initial screening.
RESULT AND ANALYSIS: In case, the mean eGFR (mean± s.d.) of patients was 25.1500 ± 11.8929. In control, the mean eGFR (mean± s.d.) of
patients was 87.2200 ± 17.8295. Difference of mean eGFR in two groups was statistically signicant (p<0.0001). In case, the mean creatinine
(mean± s.d.) of patients was 3.6350 ± 2.4419 mg/dl. In control, the mean creatinine (mean± s.d.) of patients was .9435 ± .1317 mg/dl. Difference
of mean creatinine in two groups was statistically signicant (p<0.0001).
CONCLUSION: eGFR was strongly associated with CKD that also statistically signicant. The positive correlation was found in eGFR.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.